Table SP26-1:
Antimicrobial susceptibilities for the three most commonly isolated UTI pathogens from 2009 to 2019
| MIC.(μg/mL) / % Susceptible | Organism/Year | ||||
|---|---|---|---|---|---|
| AMC | CIP | FOS | NIT | SXT | |
| E. coli/2009 | 8/94.0 | >16/78.5 | 4/99.4 | 32/98.5 | >8/75.7 |
| E. coli/2019 | 16/74.7 | >16/67.3 | 4/98.8 | 32/95.7 | >8/68.5 |
| No. of isolates | 2509 | 2389 | 1927 | 2270 | 2388 |
| K. pneumoniae/2009 | 8/95.3 | 0.5/85.9 | 64/NA | 128/10.0 | >8/87.5 |
| K. pneumoniae/2019 | 32/82.8 | 16/81.6 | 64/NA | 128/39.5 | >8/78.9 |
| No. of isolates | 424 | 433 | 179 | 268 | 433 |
| Enterococcus spp1 /2009 | 1/NA | >16/43.2 | 128/NA | 32/94.1 | 0.5/NA |
| E. faecalis/2019 | 1/NA | >16/76.5 | 128/NA | 16/97.1 | 0.5/NA |
| No. of isolates | 381 | 402 | 160 | 253 | 40 |
AMC = amoxicillin-clavulanate; CIP = ciprofloxacin; FOS = fosfomycin; NIT = nitrofurantoin; SXT = trimethoprim-sulfamethoxazole; NA = not applicable.
1 In 2009, Enterococcus spp were not speciated